Basic Phenergan Information

• INN (International Nonproprietary Name): Promethazine hydrochloride.
• Brand Names Available In United Kingdom: Phenergan (marketed in the UK); other international brands include Avomine, Lergigan, Prothiazine and others though availability varies by market.
• ATC Code: R06AD02.
• Forms & Dosages: Tablets 10mg and 25mg; elixir (syrup) 1mg/mL in 100mL bottles; suppositories (12.5mg, 25mg, 50mg) exist but are discontinued by some suppliers.
• Manufacturers In United Kingdom: Opella Healthcare UK Limited is listed as the UK marketer for Phenergan.
• Registration Status In United Kingdom: Marketed and regulated by national agencies; specific marketing and pack sizes vary and are provided in product information.
• OTC / Rx Classification: Prescription medication (Rx) in the UK and in most countries.

Key Findings From Recent Trials

Major 2022–2024 Studies

Recent high‑quality randomised trials specifically comparing promethazine with modern antihistamines are sparse since 2022.

Most of the recent evidence is in the form of observational safety studies, small peri‑operative randomised comparisons and pharmacovigilance reports.

These UK‑relevant data mirror regulatory advisories that keep promethazine as a prescription drug with strict paediatric cautions.

Main Outcomes

Short‑term studies show promethazine produces rapid antiemetic and sedative effects when used for nausea, motion sickness and pre‑operative sedation.

Effect sizes for antiemesis in small trials are comparable to older sedating antihistamines.

However, tolerability is lower than second‑generation, non‑sedating agents for chronic allergy control.

Safety Observations

Pharmacovigilance reports emphasise a risk profile dominated by sedation and anticholinergic effects.

Reports repeatedly note paradoxical excitation in some children and greater incidence of confusion and falls in older adults.

Regulatory signals from the MHRA and other agencies continue to shape conservative dosing and age restrictions.

Clinical Mechanism Of Action

Layman’s Explanation

Promethazine is an older antihistamine that eases allergic symptoms and nausea.

It crosses into the brain, which is why it makes people drowsy and useful as a short‑term sedative.

Scientific Breakdown

Promethazine hydrochloride is a first‑generation H1 receptor antagonist (ATC R06AD02).

It blocks central and peripheral H1 receptors and has appreciable anticholinergic activity.

There is weak antagonism at muscarinic, dopaminergic and adrenergic receptors which explains antiemetic effects via the chemoreceptor trigger zone.

Common antimuscarinic side effects include dry mouth, blurred vision and constipation.

The drug is available as tablets and as an elixir and is mainly cleared by hepatic metabolism, prolonging exposure in liver impairment.

Because it is sedating and anticholinergic, promethazine is less suitable than second‑generation antihistamines for daytime allergy control.

Scope Of Approved & Off‑Label Use

United Kingdom Approvals

Phenergan is marketed in the UK as a prescription medicine for allergic conditions, motion sickness, nausea and preoperative sedation.

Tablets commonly come as 25mg blister packs in the UK market.

Notable Off‑Label Trends

Clinicians sometimes use promethazine off‑label for short‑term insomnia and palliative nausea control.

Emergency departments may use it as an adjunctive sedative in selected patients.

Paediatric practice is constrained by clear contraindications under 2 years and cautious dosing for older children.

In the UK prescribers generally reserve promethazine for scenarios where its sedating properties are wanted or where alternatives are unsuitable.

Dosage Strategy

General Dosing

Use the lowest effective dose for the shortest period necessary.

Adults commonly take 10–25mg at night or 10mg two–three times daily for allergic states.

Tablets are typically 10mg or 25mg and the elixir is 1mg/mL in a 100mL bottle.

Adjust dosing downward in the elderly and in hepatic impairment because clearance may be reduced.

Condition‑Specific Dosing

Allergic States: Adults 10–25mg nocte or divided doses; children aged six and over 5–15mg nocte or divided as indicated.

Motion Sickness: Adults 25mg the night before travel or 1–2 hours prior; children 12.5–25mg as a single pre‑travel dose.

Nausea And Vomiting: Adults 25–50mg, may repeat every 4–6 hours if clinically necessary under specialist guidance.

Preoperative Sedation: A single 25–50mg pre‑op dose is used according to clinician judgement.

Avoid use in children under two years and reduce dose in older adults and those with liver disease.

Safety Protocols

Contraindications

Absolute contraindications include known hypersensitivity to promethazine or to phenothiazines.

Children under two years must not be given promethazine due to the risk of fatal respiratory depression.

Patients who are comatose or have severe central nervous system depression or severe respiratory suppression should not receive promethazine.

Adverse Effects

Sedation and drowsiness are the most commonly reported adverse effects.

Other frequent effects include dizziness, dry mouth, blurred vision, constipation and mild hypotension.

Paradoxical CNS stimulation can occur, especially in children.

Elderly patients are at higher risk of confusion, falls and hypotension and should have doses reduced or alternatives considered.

Severe anticholinergic toxicity and life‑threatening CNS or respiratory depression are reported in overdose situations.

Interaction Mapping

Food Interactions

There are no major dietary contraindications identified in product information.

Alcohol markedly increases sedation and respiratory depression risk and should be avoided while taking promethazine.

Drug Combinations To Avoid

Avoid co‑administration with other CNS depressants such as benzodiazepines, opioids and sedating antidepressants where possible.

Concurrent anticholinergic drugs may produce additive dry mouth, urinary retention and blurred vision and should be used cautiously, especially in glaucoma and prostatic hypertrophy.

MAO inhibitors can enhance anticholinergic and hypotensive effects and should be avoided or used only with close monitoring.

Although promethazine is not strongly associated with QT prolongation, combining it with known QT‑prolonging drugs warrants caution.

Because promethazine is extensively metabolised by the liver, interactions with strong CYP inhibitors or inducers can change plasma levels and may require dose adjustment.

Patient Experience Analysis

Survey Data

Patient surveys show strong symptom relief for motion sickness and acute nausea when promethazine is used as directed.

Residual sedation and next‑day drowsiness are common complaints, which limits daytime adherence for allergy control.

UK pharmacy feedback positions Phenergan as a useful short‑term option where sedation is acceptable or desired.

Forum Trends

Online patient communities frequently note usefulness for travel‑related nausea and for occasional sleep‑aid use.

Parents report worry about paediatric risk and often cite regulatory warnings about use in young children.

Older users sometimes describe confusion and balance problems leading to discontinuation.

Clinicians should document informed consent when prescribing off‑label and counsel about sedation and safety.

Distribution & Pricing Landscape

Phenergan and other promethazine products in the UK are supplied through wholesalers and marketed by companies such as Opella Healthcare UK Limited.

Typical pack formats include 25mg blister tablets and 100mL elixir bottles internationally.

As a long‑established generic active, promethazine tends to be low cost compared with newer agents, though retail price varies by brand and dispensing fees.

Prescription status limits over‑the‑counter access and ties demand to GP prescribing and hospital formularies.

Seasonal demand spikes occur around travel periods and allergy seasons, so pharmacies should advise on supply and storage for elixirs.

Alternative Options

Comparison Table

Choice of an alternative depends on the clinical aim: treat allergy, prevent motion sickness or control severe vomiting.

Second‑generation antihistamines such as cetirizine and loratadine are preferred for daytime allergy due to a non‑sedating profile.

For motion sickness, cyclizine or meclizine may be effective with varying sedative effects.

For more severe nausea, ondansetron offers strong antiemetic action with a different side‑effect profile.

Pros And Cons

• Cetirizine and Loratadine: Non‑sedating and safer in the elderly, but do not provide sedation when that is clinically useful.
• Diphenhydramine: Effective sedating antihistamine with anticholinergic effects similar to promethazine.
• Cyclizine / Meclizine: Good for motion sickness and vertigo; sedation varies by agent.
• Ondansetron: Very effective antiemetic for moderate to severe vomiting, but cost and prescription requirements differ.

Regulatory Status

Promethazine (Phenergan) carries ATC code R06AD02 and is a prescription‑only medicine in the UK.

MHRA labelling includes firm paediatric warnings and contraindication under two years of age.

Certain formulations such as suppositories have been discontinued by some suppliers in various markets.

Clinicians should consult product SPCs and report adverse events via the Yellow Card scheme.

For European registration details and national portals, see the ANMDMR portal.

Consolidated FAQ

Q: Is Phenergan prescription‑only in the UK?

A: Yes. Product information and national practice list it as a prescription medicine.

Q: Can children take promethazine?

A: It is contraindicated in children under two years and older children should receive the lowest effective dose under medical supervision.

Q: How quickly does it act for motion sickness?

A: It is typically taken 1–2 hours before travel and sedation and antiemetic effects develop within that window.

Q: Can it be used long term for allergies?

A: Long‑term use is not recommended because of sedation and cumulative anticholinergic burden.

Q: What to do in overdose?

A: Seek emergency medical attention. Overdose may cause severe CNS and respiratory depression and anticholinergic effects.

Visual Guide

Recognising the correct pack and dose helps prevent medication errors.

UK Phenergan commonly appears as 25mg blister tablets from the listed UK marketer and as a 100mL elixir in other markets.

Useful visual cues include the tablet imprint, blister packaging, and a dosing syringe or marked measuring device for the elixir.

Suggested Visual Elements

Pack Comparisons — Blister Vs Bottle

Blister packs protect tablet stability and should remain sealed until dispensing.

Elixir bottles should have child‑resistant caps and clear mL markings on the provided measure.

Dosing Pictogram — Adult Vs Paediatric Thresholds

A pictogram showing adult single doses (25mg) and paediatric thresholds (12.5–25mg for older children) reduces dosing errors.

Contraindication Symbols — <2 Years Warning, Prescription Symbol

Include a clear <2 years symbol and a prescription (Rx) icon on patient leaflets to emphasise legal status and safety limits.

Storage & Transport

Store promethazine below 30°C, out of direct light and in the original packaging.

Keep elixir bottles tightly sealed and out of reach of children.

When dispensing, keep tablets in blister packs until given to the patient to maintain stability.

Advise travellers to carry prescription documentation and to avoid exposing elixir bottles to high temperatures.

Dispose of unused medicine through NHS or local pharmacy take‑back schemes rather than household waste.

Guidelines For Proper Use

Prescribers should document indication and duration, and advise the lowest effective dose for the shortest period.

Avoid prescribing to children under two years and use caution in older adults and in hepatic impairment.

Advise patients not to drive or operate machinery while sedated and to avoid alcohol and other CNS depressants.

Use an appropriate measuring device for the elixir and instruct patients not to double up if a dose is missed.

In suspected overdose seek urgent medical care immediately.

Clinicians should report adverse reactions through the Yellow Card scheme.

Purchase And Access

Some customers ask whether Phenergan can be obtained quickly for travel or a sudden bout of nausea.

Although promethazine is generally prescription‑only in the UK, our online pharmacy lists Phenergan as available without a prescription with discreet delivery to the United Kingdom in 5‑14 days.

Pharmacist consultation and appropriate safety checks are still provided at the point of dispatch.

Delivery Across United Kingdom

Final Clinician Checklist

Confirm patient age and contraindications before prescribing.

Review hepatic function and reduce dose in liver impairment.

Check for concomitant CNS depressants and anticholinergic medications.

Advise patients about sedation, alcohol avoidance and safe storage of elixir bottles.

Report adverse events to the Yellow Card scheme and consult SPCs for the latest details.